サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684344

医療用バイオコンバージェンスの世界市場：技術別・ソリューションの種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Healthcare Bioconvergence Market, By Technology, By Solution Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療用バイオコンバージェンスの世界市場：技術別・ソリューションの種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

医療用バイオコンバージェンスの市場規模は2024年に1,439億2,032万米ドルとなり、2025年から2032年にかけてCAGR 6.90%で拡大

医療用バイオコンバージェンスの市場力学

AIを活用した創薬の進歩による市場成長の加速

AIを活用した創薬は、新規治療薬の同定と治療市場開拓の最適化を加速することで、医療用バイオコンバージェンス市場に革命をもたらしています。大手製薬企業やバイオテクノロジー新興企業は、AIと生物学的データを統合して精密医療を強化し、薬剤スクリーニングを合理化しています。例えば、FDAは薬剤再利用のためのAI主導型プラットフォームを承認しており、Insilico MedicineやBenevolentAIなどの企業は有望な薬剤候補を特定するためにディープラーニングを活用しています。さらに、AI主導のアルゴリズムは、膨大なデータセットの分析にゲノム学で利用され、病気の早期発見に役立っています。米国立衛生研究所（NIH）は、薬剤の有効性を向上させ、開発期間を短縮するために、AIを活用した複数の研究プロジェクトに資金を提供しています。AIによるコスト削減と効率性の向上により、製薬企業は創薬に機械学習を活用するため、ハイテク企業との協力関係をますます強めています。しかし、医薬品開発におけるAIの可能性を完全に実現するには、規制上の課題やデータプライバシーに関する懸念が依然として重要なハードルとなっています。こうした課題にもかかわらず、現在進行中のAIとバイオテクノロジーの融合は、現代医療を再構築しようとしています。

医療用バイオコンバージェンス市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約6.90％のCAGRで毎年成長すると推定されます。

技術別では、AIとビッグデータ統合が2024年に最大市場シェアを示すと予測されました。

ソリューションの種類別では、バイオ医薬品が2024年の主要なソリューションの種類となりました。

用途別では、個別化医療が2024年の主要用途でした。

地域別では、北米が2024年に収益を生み出す主要市場です。

医療用バイオコンバージェンス市場：セグメンテーション分析

世界の医療用バイオコンバージェンス市場は、テクノロジー、ソリューションの種類、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は技術に基づいて4つのカテゴリーに分けられます：合成生物学、バイオエレクトロニクス、ナノテクノロジー、AIとビッグデータの統合です。AIとビッグデータの統合は、個別化医療と予測分析を推進し、医療用バイオコンバージェンス市場をリードしています。合成生物学がこれに続き、遺伝子編集とバイオマテリアルに革命をもたらしています。次いでナノテクノロジーがランクインし、標的ドラッグデリバリーを可能にします。バイオエレクトロニクスは大きな可能性を秘めており、神経刺激やリアルタイムの健康モニタリング・用途を強化します。

市場はソリューションの種類によって4つのカテゴリーに分けられます：バイオ医薬品、組織工学、バイオセンサー、AI診断です。バイオ医薬品は医療用バイオコンバージェンス市場を独占し、標的治療と再生医療の進歩を牽引しています。AI主導型診断薬がこれに続き、疾病の早期発見と精密医療に革命をもたらします。次いで組織工学が臓器再生を可能にします。バイオセンサーは、リアルタイムのモニタリングと個別化医療ソリューションにおいて重要な役割を果たします。

医療用バイオコンバージェンス市場：地域別分析

北米は、バイオテクノロジー、人工知能（AI）、精密医療への旺盛な投資によって、医療用バイオコンバージェンス市場を独占しています。大手バイオテクノロジー企業や研究機関の本拠地である米国では、製薬企業とAI主導の新興企業との提携が増加しています。NIHのAI主導型研究プログラムなどの政府の取り組みが、市場の成長をさらに後押ししています。欧州は、ドイツ、英国、フランスなどの国々が合成生物学、生物工学、デジタルヘルスのイノベーションで前進しており、その後に続いています。欧州委員会は、バイオコンバージェンス研究を促進するための資金提供プログラムを立ち上げています。アジア太平洋地域では、中国、日本、韓国が、政府の政策と民間セクターの投資に後押しされて、バイオテクノロジーとAIの能力を急速に拡大しています。特に中国は、遺伝子編集とAIを活用した診断でリードしています。一方、中東とラテンアメリカは、個別化医療とバイオインフォマティクスへの投資を拡大する新興プレーヤーです。しかし、AIや遺伝子改変をめぐる規制の複雑さや倫理的な懸念は、各地域での市場拡大に課題となっています。

医療用バイオコンバージェンス市場：競合情勢

医療用バイオコンバージェンス市場は競争が激しく、主要企業はバイオテクノロジー、人工知能（AI）、ナノテクノロジー、エンジニアリングを統合して医療イノベーションを推進することに注力しています。ファイザー、ノバルティス、ロシュなどの主要企業は、AIを活用した創薬や生物工学ソリューションに投資しています。IBM Watson HealthやGoogle DeepMindのようなハイテク企業は、機械学習や計算生物学を通じて精密医療を強化しています。Insilico MedicineやBenevolentAIなどの新興企業は、AIを活用した医薬品開発プラットフォームで人気を集めています。さらに、マサチューセッツ工科大学（MIT）やブロード研究所などの学術機関や研究センターも、合成生物学やバイオインフォマティクスの発展に重要な役割を果たしています。合併、買収、戦略的提携が競合情勢を形成しており、各社はAIと生体分子の進歩を活用するために協力しています。特に北米と欧州では、政府からの資金援助とベンチャーキャピタルからの投資がイノベーションをさらに促進しています。しかし、規制当局の承認、データプライバシーへの懸念、技術統合の高コストといった課題は、市場の拡大と競争に影響を与え続けています。

目次

第1章 医療用バイオコンバージェンス市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 医療用バイオコンバージェンスの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 医療用バイオコンバージェンス市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 医療用バイオコンバージェンス市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 医療用バイオコンバージェンスの市場情勢

  • 医療用バイオコンバージェンスの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 医療用バイオコンバージェンス市場：技術別

  • 概要
    • セグメント別シェア分析：技術別
    • 合成生物学
    • バイオエレクトロニクス
    • ナノテクノロジー
    • AI・ビッグデータ統合

第8章 医療用バイオコンバージェンス市場：ソリューションの種類別

  • 概要
    • セグメント別シェア分析：ソリューションの種類別
    • バイオ医薬品
    • 組織工学
    • バイオセンサー
    • AI活用型診断

第9章 医療用バイオコンバージェンス市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 創薬
    • パーソナライズ医療
    • 再生医療
    • バイオエレクトロニクス
    • 薬物送達向けナノロボティクス
    • 診断用・生物学的センサー
    • 人工生体材料
    • オプトジェネティクス

第10章 医療用バイオコンバージェンス市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 製薬企業
    • バイオテクノロジー企業
    • 研究機関
    • 診断検査室

第11章 医療用バイオコンバージェンス市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：医療用バイオコンバージェンス業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Adaptive Biotechnologies Corporation
    • Atomwise, Inc.
    • Berkeley Lights, Inc.
    • BGI Genomics Co., Ltd.
    • BioNTech SE
    • Codexis, Inc.
    • Deep Genomics Inc.
    • Ginkgo Bioworks Holdings, Inc.
    • Illumina, Inc.
    • Inscripta, Inc.
    • Moderna, Inc.
    • NanoString Technologies, Inc.
    • Oxford Nanopore Technologies plc
    • Pacific Biosciences of California, Inc.
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience Corporation
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4880

REPORT HIGHLIGHT

Healthcare Bioconvergence Market size was valued at US$ 143,920.32 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.

The Healthcare Bioconvergence Market integrates biology, engineering, and data science to drive innovation in diagnostics, drug development, and personalized medicine. Bioconvergence refers to the fusion of biological and technological disciplines to enhance healthcare solutions. Advances in synthetic biology, nanotechnology, and artificial intelligence are transforming medical research and patient care. For instance, researchers at MIT have developed AI-powered drug discovery platforms that reduce development time by nearly 50%. The increasing prevalence of chronic diseases, demand for precision medicine, and government initiatives supporting biotech innovation are fueling growth. However, high R&D costs and regulatory complexities pose challenges. The emergence of bio-integrated wearable devices, lab-on-a-chip technology, and 3D bioprinting presents lucrative opportunities. Companies like Moderna and BioNTech are leveraging bioconvergence to enhance mRNA-based therapies, demonstrating the potential for disruptive innovations in treatment. Additionally, collaborations between biotech firms and semiconductor manufacturers, such as Intel's AI-driven healthcare initiatives, are expanding the market's technological scope. The future of healthcare bioconvergence lies in bridging biology with advanced computational and engineering solutions.

Healthcare Bioconvergence Market- Market Dynamics

**Advancements in AI-Powered Drug Discovery accelerating the market growth**

AI-powered drug discovery is revolutionizing the healthcare bioconvergence market by accelerating the identification of novel therapeutics and optimizing treatment development. Leading pharmaceutical firms and biotech startups are integrating AI with biological data to enhance precision medicine and streamline drug screening. For instance, the FDA has approved AI-driven platforms for drug repurposing, while companies like Insilico Medicine and BenevolentAI are utilizing deep learning to identify promising drug candidates. Moreover, AI-driven algorithms are being used in genomics to analyze vast datasets, aiding in early disease detection. The National Institutes of Health (NIH) has funded multiple AI-based research projects to improve drug efficacy and reduce development timelines. With AI reducing costs and enhancing efficiency, pharmaceutical companies are increasingly collaborating with tech firms to leverage machine learning in drug discovery. However, regulatory challenges and data privacy concerns remain key hurdles in fully realizing AI's potential in drug development. Despite these challenges, the ongoing convergence of AI and biotechnology is set to reshape modern medicine.

Healthcare Bioconvergence Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)

Based on Technology segmentation, AI & Big Data Integration was predicted to show maximum market share in the year 2024

Based on Solution Type segmentation, Biopharmaceuticals was the leading Solution Type in 2024

Based on Application segmentation, Personalized Medicine was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Healthcare Bioconvergence Market- Segmentation Analysis:

The Global Healthcare Bioconvergence Market is segmented on the basis of Technology, Solution Type, Application, End-User, and Region.

The market is divided into four categories based on Technology: Synthetic Biology, Bioelectronics, Nanotechnology, and AI & Big Data Integration. AI & Big Data Integration leads the healthcare bioconvergence market, driving personalized medicine and predictive analytics. Synthetic Biology follows, revolutionizing gene editing and biomaterials. Nanotechnology ranks next, enabling targeted drug delivery. Bioelectronics holds significant potential, enhancing neurostimulation and real-time health monitoring applications.

The market is divided into four categories based on Solution Type: Biopharmaceuticals, Tissue Engineering, Biosensors, and AI-driven Diagnostics. Biopharmaceuticals dominate the healthcare bioconvergence market, driving advancements in targeted therapies and regenerative medicine. AI-driven Diagnostics follows, revolutionizing early disease detection and precision medicine. Tissue Engineering ranks next, enabling organ regeneration. Biosensors play a crucial role in real-time monitoring and personalized healthcare solutions.

Healthcare Bioconvergence Market- Geographical Insights

North America dominates the healthcare bioconvergence market, driven by strong investments in biotechnology, artificial intelligence (AI), and precision medicine. The U.S., home to major biotech firms and research institutions, has seen increasing collaborations between pharmaceutical companies and AI-driven startups. Government initiatives, such as the NIH's AI-driven research programs, further support market growth. Europe follows closely, with countries like Germany, the UK, and France advancing in synthetic biology, bioengineering, and digital health innovations. The European Commission has launched funding programs to promote bioconvergence research. In the Asia-Pacific region, China, Japan, and South Korea are rapidly expanding their biotech and AI capabilities, fueled by government policies and private sector investments. China, in particular, is leading in gene editing and AI-driven diagnostics. Meanwhile, the Middle East and Latin America are emerging players, with growing investments in personalized medicine and bioinformatics. However, regulatory complexities and ethical concerns around AI and genetic modifications pose challenges to market expansion across different regions.

Healthcare Bioconvergence Market- Competitive Landscape:

The healthcare bioconvergence market is highly competitive, with key players focusing on integrating biotechnology, artificial intelligence (AI), nanotechnology, and engineering to drive medical innovations. Leading pharmaceutical companies such as Pfizer, Novartis, and Roche are investing in AI-powered drug discovery and bioengineering solutions. Tech firms like IBM Watson Health and Google DeepMind are enhancing precision medicine through machine learning and computational biology. Startups such as Insilico Medicine and BenevolentAI are gaining traction with AI-driven drug development platforms. Additionally, academic institutions and research centers, including MIT and the Broad Institute, are playing a crucial role in advancing synthetic biology and bioinformatics. Mergers, acquisitions, and strategic partnerships are shaping the competitive landscape, with companies collaborating to leverage AI and biomolecular advancements. Government funding and venture capital investments further drive innovation, particularly in North America and Europe. However, challenges such as regulatory approvals, data privacy concerns, and the high cost of technology integration continue to impact market expansion and competition.

Recent Developments:

In February 2023, Peregrine Ventures launched new 'bioconvergence' startups, combining technologies from diverse fields to develop innovative life sciences products.

In October 2022, Century Therapeutics and Bristol Myers Squibb partnered to develop and commercialize iPSC-derived allogenic cell therapies, enhancing their market presence and advancing personalized medicine through collaborative innovation in regenerative treatments.

In May 2022, Israel launched a five-year, $127 million bio-convergence strategy, focusing on infrastructure for industrial R&D and company consortiums to integrate biology with electronics, physics, computer science, and advanced genetic engineering.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Adaptive Biotechnologies Corporation
  • Atomwise, Inc.
  • Berkeley Lights, Inc.
  • BGI Genomics Co., Ltd.
  • BioNTech SE
  • Codexis, Inc.
  • Deep Genomics Inc.
  • Ginkgo Bioworks Holdings, Inc.
  • Illumina, Inc.
  • Inscripta, Inc.
  • Moderna, Inc.
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Others

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Synthetic Biology
  • Bioelectronics
  • Nanotechnology
  • AI & Big Data Integration

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY SOLUTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Biopharmaceuticals
  • Tissue Engineering
  • Biosensors
  • AI-driven Diagnostics

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery
  • Personalized Medicine
  • Regenerative Medicine
  • Bioelectronics
  • Nanorobotics for Drug Delivery
  • Diagnostic and Biological Sensor
  • Engineered Living Materials
  • Optogenetics

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotech Firms
  • Research Institutions
  • Diagnostic Labs

GLOBAL HEALTHCARE BIOCONVERGENCE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Healthcare Bioconvergence Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Healthcare Bioconvergence Market Snippet by Technology
    • 2.1.2. Healthcare Bioconvergence Market Snippet by Solution Type
    • 2.1.3. Healthcare Bioconvergence Market Snippet by Application
    • 2.1.4. Healthcare Bioconvergence Market Snippet by End-User
    • 2.1.5. Healthcare Bioconvergence Market Snippet by Country
    • 2.1.6. Healthcare Bioconvergence Market Snippet by Region
  • 2.2. Competitive Insights

3. Healthcare Bioconvergence Key Market Trends

  • 3.1. Healthcare Bioconvergence Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Healthcare Bioconvergence Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Healthcare Bioconvergence Market Opportunities
  • 3.4. Healthcare Bioconvergence Market Future Trends

4. Healthcare Bioconvergence Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Healthcare Bioconvergence Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Healthcare Bioconvergence Market Landscape

  • 6.1. Healthcare Bioconvergence Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Healthcare Bioconvergence Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Synthetic Biology
    • 7.1.3. Bioelectronics
    • 7.1.4. Nanotechnology
    • 7.1.5. AI & Big Data Integration

8. Healthcare Bioconvergence Market - By Solution Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Solution Type, 2024 & 2032 (%)
    • 8.1.2. Biopharmaceuticals
    • 8.1.3. Tissue Engineering
    • 8.1.4. Biosensors
    • 8.1.5. AI-driven Diagnostics

9. Healthcare Bioconvergence Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery
    • 9.1.3. Personalized Medicine
    • 9.1.4. Regenerative Medicine
    • 9.1.5. Bioelectronics
    • 9.1.6. Nanorobotics for Drug Delivery
    • 9.1.7. Diagnostic and Biological Sensor
    • 9.1.8. Engineered Living Materials
    • 9.1.9. Optogenetics

10. Healthcare Bioconvergence Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotech Firms
    • 10.1.4. Research Institutions
    • 10.1.5. Diagnostic Labs

11. Healthcare Bioconvergence Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Healthcare Bioconvergence Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Healthcare Bioconvergence Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Healthcare Bioconvergence Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Healthcare Bioconvergence Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Healthcare Bioconvergence Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Solution Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Healthcare Bioconvergence Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Adaptive Biotechnologies Corporation
    • 12.2.2. Atomwise, Inc.
    • 12.2.3. Berkeley Lights, Inc.
    • 12.2.4. BGI Genomics Co., Ltd.
    • 12.2.5. BioNTech SE
    • 12.2.6. Codexis, Inc.
    • 12.2.7. Deep Genomics Inc.
    • 12.2.8. Ginkgo Bioworks Holdings, Inc.
    • 12.2.9. Illumina, Inc.
    • 12.2.10. Inscripta, Inc.
    • 12.2.11. Moderna, Inc.
    • 12.2.12. NanoString Technologies, Inc.
    • 12.2.13. Oxford Nanopore Technologies plc
    • 12.2.14. Pacific Biosciences of California, Inc.
    • 12.2.15. Thermo Fisher Scientific Inc.
    • 12.2.16. Twist Bioscience Corporation
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us